Skip to content
The Policy VaultThe Policy Vault

SovaldiCigna

Patient continuing therapy with Sovaldi

Preferred products

  • Epclusa (brand)

Initial criteria

  • For new start pediatric genotype 2 or 3 patients: Sovaldi is not approved; offer to review for Epclusa (brand only) using standard Hepatitis C – Epclusa PA Policy criteria
  • For patients continuing therapy: refer to the standard Hepatitis C – Sovaldi PA Policy criteria

Approval duration

per respective Hepatitis C PA Policy